Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04564027
Title A Study Investigating DNA-damage Response Agents in Molecularly Altered Advanced Cancer
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors AstraZeneca
Indications

Advanced Solid Tumor

prostate cancer

Therapies

Ceralasertib

Age Groups: adult | senior
Covered Countries USA

Additional content available in CKB BOOST